Last Price | 119.80 | Max Price | 157.30 |
Min Price | 119.80 | 1 Year return | 0.00 |
Avg. Target | 156.17 | Expected Return | 30.36 % |
Sector | Health Care | Subsector | Pharmaceuticals |
Sell | 1 | Rating | |
Hold | 1 | Concensus | |
Buy | 4 |
Contact info:Country: Germany
Year | Turnover | Total sector | Market share |
---|---|---|---|
2019 | 0 | 615,670 | 0.00 % |
2020 | 0 | 638,104 | 0.00 % |
2021 | 0 | 727,997 | 0.00 % |
2022 | 0 | 787,317 | 0.00 % |
2023 | 0 | 0 | 0.00 % |
Date Label | Bank Label | Stock Label | Advice Label | Price Label | Diff Label |
---|---|---|---|---|---|
October 22, 2024 | HSBC | Redcare Pharmacy | Hold | 160.00 | 25.12 % |
September 03, 2024 | Jefferies & Co. | Redcare Pharmacy | Buy | 170.00 | 29.53 % |
August 25, 2024 | UBS | Redcare Pharmacy | Sell | 83.00 | -44.34 % |
July 31, 2024 | Baader Bank | Redcare Pharmacy | Buy | 175.00 | 31.54 % |
July 31, 2024 | M.M. Warburg & Co. | Redcare Pharmacy | Buy | 174.00 | 31.15 % |
March 17, 2024 | Hauck & Aufhauser | Redcare Pharmacy | Buy | 175.00 | 31.54 % |
July 31, 2024 | Jefferies & Co. | Redcare Pharmacy | Buy | 180.00 | 33.44 % |
July 04, 2024 | UBS | Redcare Pharmacy | Sell | 86.00 | -39.30 % |
April 12, 2024 | Jefferies & Co. | Redcare Pharmacy | Buy | 180.00 | 33.44 % |
March 22, 2024 | HSBC | Redcare Pharmacy | Hold | 140.00 | 14.43 % |
March 17, 2024 | Jefferies & Co. | Redcare Pharmacy | Buy | 160.00 | 25.12 % |
March 17, 2024 | M.M. Warburg & Co. | Redcare Pharmacy | Hold | 138.00 | 13.19 % |
January 15, 2024 | Baader Bank | Redcare Pharmacy | Buy | 125.00 | 0.72 % |
No Records Found
No Records Found
No Records Found
Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Revenue |
0
|
0
|
0
|
0
|
0
|
|
Costs |
0
|
0
|
0
|
0
|
0
|
|
Profit |
0
|
0
|
0
|
0
|
0
|
|
Margin of profit |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
ROI |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Equity |
0
|
0
|
0
|
0
|
0
|
|
Debt |
0
|
0
|
0
|
0
|
0
|
|
Total assets |
0
|
0
|
0
|
0
|
0
|
|
Solvency |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
Cash |
0
|
0
|
0
|
0
|
0
|
|
Cashflow |
0
|
0
|
0
|
0
|
0
|
|
Employees |
0
|
0
|
0
|
0
|
0
|
|
Revenue per employee |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
Cashflow / Debt |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
Details |
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|
Price |
0.0
|
0.0
|
0.0
|
0.0
|
119.80
|
Eps |
0.0
|
0.0
|
0.0
|
0.0
|
|
Price/earnings-ratio |
0.0
|
0.0
|
0.0
|
0.0
|
|
Dividend |
0.0
|
0.0
|
0.0
|
0.0
|
|
Dividend % |
0.00 %
|
0.00 %
|
0.00 %
|
0.00 %
|
|
Payout % |
0.0
|
0.0
|
0.0
|
0.0
|
|
Book value |
0.0
|
0.0
|
0.0
|
0.0
|
|
Market to book |
0.0
|
0.0
|
0.0
|
0.0
|
|
Cashflow per stock |
0.0
|
0.0
|
0.0
|
0.0
|
|
Stocks |
0
|
0
|
0
|
0
|
|
Market Cap |
0.00
|
0.00
|
0.00
|
0.00
|
|
Date
|
Price
|
---|---|
17 Jan 2025
|
119.80
|
09 Jan 2025
|
124.10
|
17 Dec 2024
|
148.40
|
10 Dec 2024
|
157.30
|
06 Dec 2024
|
154.80
|
03 Dec 2024
|
150.00
|
29 Nov 2024
|
147.60
|